Retinai

RetinAI provides an AI-driven data management platform designed specifically for the field of ophthalmology. The platform enables healthcare professionals, hospitals, clinics, and pharmaceutical companies to collect, organize, and analyze medical imaging data at scale.

Users can centralize a broad range of medical images and datasets, including OCT, fundus images, and various standard formats. Built-in AI models automate image analysis, disease progression tracking, and extraction of clinically-relevant insights, supporting research, clinical trials, and patient management.

The platform is vendor-neutral—integrating with major imaging systems and supporting secure, cloud-based collaboration across stakeholders. Advanced annotation tools and CE-marked algorithms provide reliability and regulatory compliance for use in clinical and research contexts.

By accelerating data processing and enabling real-time insights on patient outcomes and treatment efficacy, RetinAI supports precision medicine and helps advance drug development and clinical research in ophthalmology.

RetinAI is designed for professionals working in ophthalmology, including clinicians, researchers, and data scientists at hospitals, eye clinics, and academic medical centers.

Pharmaceutical and life sciences companies running clinical studies for eye diseases use the platform to centralize diverse imaging data, automate analysis, and accelerate R&D and trials. Hospital IT and data teams benefit from its compatibility with standard and proprietary medical image formats, enabling them to manage imaging workflows efficiently.

It is also suitable for clinical operations managers overseeing multi-site research projects, offering tools for global collaboration and regulatory compliance when developing new diagnostics or therapies.